Time-kill kinetic studies of ampicillin/sulbactam for β-Lactamase-producing enterococci

Jan E Patterson, Patricia Farrel, Marcus J. Zervos

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

β-Lactamase-producing (Bla+ enterococci have now been reported from several geographic areas. Most of these strains also demonstrate high-level aminoglycoside resistance, making therapy of serious infections due to Bla+ enterococci difficult. Using time-kill kinetic studies, we evaluated the activity of ampicillin-sulbactam (Am/SB) against five clinical Bla+ Enterococcus faecalis isolates from three geographically distinct areas. Am at fourfold minimum inhibitory concentrations (MIC) concentrations did not achieve bactericidal activity as determined by time-kill kinetic studies. Am/SB achieved 99.9% reduction in growth at 24 hr at twofold MIC concentrations without an aminoglycoside in four of five strains. SB alone had little independent activity against any of the strains, but synergy of killing was achieved in all five strains with a combination of Am + SB. No synergy was shown in a Bla- control strain. Am/SB may be useful for serious infections due to Bla+ enterococci.

Original languageEnglish (US)
Pages (from-to)495-499
Number of pages5
JournalDiagnostic Microbiology and Infectious Disease
Volume14
Issue number6
DOIs
StatePublished - 1991
Externally publishedYes

Fingerprint

Enterococcus
Microbial Sensitivity Tests
Aminoglycosides
Enterococcus faecalis
Infection
Growth
sultamicillin
Therapeutics

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Immunology
  • Microbiology
  • Parasitology
  • Virology
  • Immunology and Allergy
  • Infectious Diseases

Cite this

Time-kill kinetic studies of ampicillin/sulbactam for β-Lactamase-producing enterococci. / Patterson, Jan E; Farrel, Patricia; Zervos, Marcus J.

In: Diagnostic Microbiology and Infectious Disease, Vol. 14, No. 6, 1991, p. 495-499.

Research output: Contribution to journalArticle

@article{11cfd3308ca04c2ba6f20a1317246289,
title = "Time-kill kinetic studies of ampicillin/sulbactam for β-Lactamase-producing enterococci",
abstract = "β-Lactamase-producing (Bla+ enterococci have now been reported from several geographic areas. Most of these strains also demonstrate high-level aminoglycoside resistance, making therapy of serious infections due to Bla+ enterococci difficult. Using time-kill kinetic studies, we evaluated the activity of ampicillin-sulbactam (Am/SB) against five clinical Bla+ Enterococcus faecalis isolates from three geographically distinct areas. Am at fourfold minimum inhibitory concentrations (MIC) concentrations did not achieve bactericidal activity as determined by time-kill kinetic studies. Am/SB achieved 99.9{\%} reduction in growth at 24 hr at twofold MIC concentrations without an aminoglycoside in four of five strains. SB alone had little independent activity against any of the strains, but synergy of killing was achieved in all five strains with a combination of Am + SB. No synergy was shown in a Bla- control strain. Am/SB may be useful for serious infections due to Bla+ enterococci.",
author = "Patterson, {Jan E} and Patricia Farrel and Zervos, {Marcus J.}",
year = "1991",
doi = "10.1016/0732-8893(91)90005-Z",
language = "English (US)",
volume = "14",
pages = "495--499",
journal = "Diagnostic Microbiology and Infectious Disease",
issn = "0732-8893",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Time-kill kinetic studies of ampicillin/sulbactam for β-Lactamase-producing enterococci

AU - Patterson, Jan E

AU - Farrel, Patricia

AU - Zervos, Marcus J.

PY - 1991

Y1 - 1991

N2 - β-Lactamase-producing (Bla+ enterococci have now been reported from several geographic areas. Most of these strains also demonstrate high-level aminoglycoside resistance, making therapy of serious infections due to Bla+ enterococci difficult. Using time-kill kinetic studies, we evaluated the activity of ampicillin-sulbactam (Am/SB) against five clinical Bla+ Enterococcus faecalis isolates from three geographically distinct areas. Am at fourfold minimum inhibitory concentrations (MIC) concentrations did not achieve bactericidal activity as determined by time-kill kinetic studies. Am/SB achieved 99.9% reduction in growth at 24 hr at twofold MIC concentrations without an aminoglycoside in four of five strains. SB alone had little independent activity against any of the strains, but synergy of killing was achieved in all five strains with a combination of Am + SB. No synergy was shown in a Bla- control strain. Am/SB may be useful for serious infections due to Bla+ enterococci.

AB - β-Lactamase-producing (Bla+ enterococci have now been reported from several geographic areas. Most of these strains also demonstrate high-level aminoglycoside resistance, making therapy of serious infections due to Bla+ enterococci difficult. Using time-kill kinetic studies, we evaluated the activity of ampicillin-sulbactam (Am/SB) against five clinical Bla+ Enterococcus faecalis isolates from three geographically distinct areas. Am at fourfold minimum inhibitory concentrations (MIC) concentrations did not achieve bactericidal activity as determined by time-kill kinetic studies. Am/SB achieved 99.9% reduction in growth at 24 hr at twofold MIC concentrations without an aminoglycoside in four of five strains. SB alone had little independent activity against any of the strains, but synergy of killing was achieved in all five strains with a combination of Am + SB. No synergy was shown in a Bla- control strain. Am/SB may be useful for serious infections due to Bla+ enterococci.

UR - http://www.scopus.com/inward/record.url?scp=0025951565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025951565&partnerID=8YFLogxK

U2 - 10.1016/0732-8893(91)90005-Z

DO - 10.1016/0732-8893(91)90005-Z

M3 - Article

C2 - 1802536

AN - SCOPUS:0025951565

VL - 14

SP - 495

EP - 499

JO - Diagnostic Microbiology and Infectious Disease

JF - Diagnostic Microbiology and Infectious Disease

SN - 0732-8893

IS - 6

ER -